skip to content


Mediclinic updates on Zurich VVG levy

10 April 2017 13:53

Mediclinic International has announced that the Zurich Cantonal Parliament voted not to approve the proposed VVG levy on the proportion of privately insured patients treated in listed hospitals, including Klinik Hirslanden.

The Company also confirmed that that the Swiss national outpatient tariff ("TARMED") was still in revision.

The Swiss Federal Government has released proposed adjustments as a transitional solution whilst healthcare providers and funders continue to negotiate and agree a revised TARMED tariff structure.

Commenting today, Ole Wiesinger, CEO of Hirslanden, said:

"We acknowledge that the Zurich Cantonal Parliament has followed the recommendation of the Finance Commission and voted not to approve the proposed Zurich VVG levy and recognise that ongoing dialogue and engagement with the relevant public authorities is key to ensuring that we can continue to deliver high-quality, cost-efficient, healthcare to our patients."

At 1:53pm: (LON:MDC) Mediclinic International Plc share price was +22.5p at 722p

Story provided by

Related Company: MDC

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.